OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation Activity
Xinyi Wu, Ping Sun, Xiuhui Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 18, pp. 11985-12001
Closed Access | Times Cited: 10

Showing 10 citing articles:

The role of inflammasomes in human diseases and their potential as therapeutic targets
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 61

Inflammasome: structure, biological functions, and therapeutic targets
Dai Ya-li, Jing Zhou, Chunmeng Shi
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 29

Medicinal chemistry strategies targeting NLRP3 inflammasome pathway: A recent update from 2019 to mid-2023
Meibo Duan, Lei Sun, Xinzi He, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115750-115750
Closed Access | Times Cited: 16

Hit-to-Lead Optimization of the Natural Product Oridonin as Novel NLRP3 Inflammasome Inhibitors with Potent Anti-Inflammation Activity
Chen He, Junkai Liu, Junda Li, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 9406-9430
Closed Access | Times Cited: 5

Discovery, Synthesis, and Biological Mechanism Evaluation of Novel Quinoline derivatives as Potent NLRP3 Inhibitors
Ruiwen Wu, Yuyun Yan, Zhuorong Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117466-117466
Closed Access

A Perfect Storm: The Convergence of Aging, Human Immunodeficiency Virus Infection, and Inflammasome Dysregulation
Siva Thirugnanam, Namita Rout
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4768-4786
Open Access | Times Cited: 1

Design, Synthesis, in Vitro and in Vivo Biological Evaluation of Pterostilbene Derivatives for the Treatment of Inflammatory Bowel Disease
Xingxing Zhang, Bin Li, Xiaohan Liu, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 11
Open Access | Times Cited: 1

Discovery of a dual-acting inhibitor of interleukin-1β and STATs for the treatment of inflammatory bowel disease
Haowei Cai, Zhuorong Liu, Ping Sun, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 193-206
Open Access | Times Cited: 4

The intricate interactions between inflammasomes and bacterial pathogens: Roles, mechanisms, and therapeutic potentials
Jin Kyung Kim, Asmita Sapkota, Taylor Roh, et al.
Pharmacology & Therapeutics (2024), pp. 108756-108756
Open Access

Page 1

Scroll to top